Archive for the ‘Hospital Clínic de Barcelona’ Category

Categories

Posted in:

Monday June 26th, 2017

Jaume Bosch coordinates the guidance on the management of portal hypertensive bleeding in cirrhosis published in Hepatology

Hepatology, the official journal of the American Association for the Study of Liver Diseases, has published a practice guidance entitled Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis, and Management. The study is coordinated by Dr. Jaume Bosch, hepatologist at Hospital Clínic and head of the research team Liver hemodynamics and portal hypertension at IDIBAPS. The other three authors, Dr. Juan G. Abraldes and Dr. Annalisa Berzigotti, are former IDIBAPS researchers, and Dr. Guadalupe Garcia-Tsao made a stay at this institution. The main newness of this guidance is the adaptation of the treatments to the various phases of cirrhosis. Read the rest of this entry »

Comments Closed
Monday June 12th, 2017

Aleix Prat, named Board Member of the Breast International Group

Dr. Aleix Prat, Head of the Clinical Oncology Department at Hospital Clínic and of the Translational genomics and targeted therapeutics in solid tumors research team at IDIBAPS, has been named member of the Executive Board of the Breast International Group (BIG). The BIG is an international non-profit organisation that includes more than 56 cooperative groups from around the world, more than 10,000 experts and it is linked to more than 3,000 hospitals. Its main goal is to promote clinical and translational research in breast cancer. The appointment, which represents a recognition to his professional career in this field, took place during the annual meeting of the American Society of Clinical Oncology (ASCO) held in June 2-6 in Chicago. Read the rest of this entry »

Comments Closed
Thursday June 08th, 2017

Josep Dalmau, awarded with the Rey Jaime I prize in the Clinical Medicine category

Dr. Josep Dalmau, Professor ICREA at IDIBAPS, where he leads the clinical and experimental Neuroimmunology team, and consultant of the Neurology Department at Hospital Clínic, has been awarded the Rey Jaime I Prize in the Clinical Medicine category . Dr. Dalmau is also a professor in the Department of Medicine at the Faculty of Medicine and Health Sciences of the University of Barcelona (UB). This is the third consecutive year that a Hospital Clinic-IDIBAPS researcher receives this prestigious award. Read the rest of this entry »

Comments Closed
Tuesday May 02nd, 2017

FreeOx Biotech acquires the rights of two compounds to treat neurological and cardiovascular diseases

Dr. Ángel Chamorro, Head of the Functional Unit of Cerebral Vascular Pathology at Hospital Clínic de Barcelona, ​​has developed two compounds with neuroprotective properties based on reducing the effects of oxidative stress on the body. Hospital Clínic and the Clínic Foundation for Biomedical Research, with the support of the IDIBAPS’s KTT office (Knowledge and Technology Transfer), have signed an exclusive license agreement with FreeOx Biotech for the development and exploitation of this technology. Read the rest of this entry »

Comments Closed
Thursday April 20th, 2017

A study reveals the biological changes in breast cancer between the primary tumor and metastases

A study published in the journal Cancer Research underscores the importance of the molecular characterization of the metastases in breast cancer. Researchers have described, for the first time, that the longer the time from the onset of the tumor to the development of metastasis is, the more aggressive this cancer becomes. They have also shown that between the initial tumor and the metastasis the subtype of breast cancer can change in up to 40% of cases. The work has been coordinated by Aleix Prat, Head of the Oncology Department of the Hospital Clínic, Head of the Translational Genomics team and directed therapies in solid tumors IDIBAPS team and Head of the VHIO Translational Genomics Group. The first author of the study is Juan Miguel Cejalvo, PhD student of the PhD4MD program in the group led by Aleix Prat at IDIBAPS and in the Growth Control and Cancer Metastasis group of the Institute for Research in Biomedicine (IRB Barcelona), led by the ICREA researcher Roger Gomis.

Read the rest of this entry »

Comments Closed
Wednesday April 05th, 2017

Elías Campo takes office as Director of IDIBAPS

Yesterday, Tuesday, April 4th, Elías Campo took office as the new Director of IDIBAPS replacing Ramon Gomis, who has held the position since 2008. The election of the new director was made after an international call and an open selection process. Elías Campo is Research and Innovation Director of Hospital Clínic, Director of the Clinic Foundation and responsible for the group Molecular pathology of lymphoid neoplasms of IDIBAPS. He is also full professor in the Faculty of Medicine and Health Sciences at the University of Barcelona. Read the rest of this entry »

Comments Closed
Page 1 of 5712345...Last »